Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Threshold Pharmaceuticals Inc (NASDAQ:THLD)

4.34
Delayed Data
As of Aug 28
 +0.09 / +2.12%
Today’s Change
2.58
Today|||52-Week Range
5.41
+36.48%
Year-to-Date
No recent news for Threshold Pharmaceuticals Inc.

Today’s Trading

Previous close4.25
Today’s open4.23
Day’s range4.19 - 4.38
Volume865,918
Average volume (3 months)633,002
Market cap$303.2M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)0.00%
Earnings growth (this year)-6.80%
Earnings growth (next 5 years)--
Revenue growth (last year)+17.82%
P/E ratioNM
Price/Sales13.69
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SVASinovac Biotech Ltd+0.15+2.76%
FOMXFoamix Pharmaceutica...+0.09+0.89%
CCXIChemoCentryx Inc-0.39-5.66%
CPRXCatalyst Pharmaceuti...-0.02-0.55%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$14.7M
Annual profit (last year)-$21.6M
Net profit margin-146.61%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Harold E. Selick
Vice President-Finance &
Controller
Joel A. Fernandes
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers